Clinical Trial

Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-01 -> 2026-09-01 2026-07-07
minor Completion pushed: 2026-06-01 -> 2026-09-01 2026-07-07
Trial Details
NCT Number NCT04895956
Lead Sponsor University of California, Davis
Conditions De Quervain Tenosynovitis
Enrollment 80 participants
Start Date 2022-01-24
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06